For clinics offering botulinum toxin treatments, a firm grasp of Azzalure injection technique is central to safe, consistent outcomes. This guide explains how Azzalure injections are administered, the injection points practitioners rely on, and the side effects and benefits patients can reasonably expect.
Learn about administration technique, Azzalure injection sites and doses, expected side effects, and the documented benefits of Azzalure in clinical use.
At Medica Depot, we work with licensed professionals who source Azzalure for their aesthetic practices, and these notes are intended to support clinicians as they refine their approach to Azzalure injection points and dosing. Clinics looking to order Azzalure online can also review current product availability and batch documentation through our team.
Key Takeaways
- Azzalure (abobotulinumtoxinA) is licensed for the temporary improvement of moderate to severe glabellar lines and lateral canthal lines in adults under 65.
- Administration follows a precise five-point (glabellar) or three-point-per-side (lateral canthal) intramuscular technique that trained, licensed practitioners should perform and document with accurate injection records.
- Azzalure and Botox use non-interchangeable dosing units, which has practical implications for technique and injection-site selection.
About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. We offer a worry-free experience in searching for the best and most popular products on the market, like Azzalure. Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.
What Are the Common Azzalure Injection Points?
The licensed Azzalure injection points are specific and limited by design, which supports a predictable, repeatable technique. Treatment for glabellar lines (the vertical furrows between the eyebrows) involves five sites: two injections into each corrugator muscle, and one into the procerus muscle near the nasofrontal angle [1].
For the licensed lateral canthal indication (crow’s feet), the recommended regimen is three injection sites per side. Place these superficially in the outer portion of the orbicularis oculi muscle, roughly 1–2 cm from the orbital rim [1].
Practitioners should identify these facial muscles by observing and palpating the area at maximum frown or maximum smile, since landmarks shift with expression [1]. Botulinum toxin type A is also used off-label across other facial and neck muscles in aesthetic practice. That said, Azzalure’s licensed treatment areas are the glabellar and lateral canthal regions.
How Is an Azzalure Injection Administered?
Only a healthcare practitioner trained and licensed in the technique should administer Azzalure, with the appropriate equipment on hand [1]. Before injection, remove makeup and disinfect the skin with a local antiseptic. Injections are then delivered intramuscularly using a sterile needle of suitable gauge. For glabellar sites, place the needle at a right angle to the skin, and at a shallow 20–30° angle for lateral canthal sites [1].
Injection site preparation also includes a careful review of the patient’s facial anatomy. Asymmetry, ptosis, scarring, or prior surgical changes can all affect placement decisions [1]. After treatment, regulatory guidance requires a clear Azzalure injection record. Practitioners should document the product name and batch number for every patient, which supports traceability across treatment cycles [1]. Retreatment intervals should be no more frequent than every three months [1]. Reliable outcomes across cycles depend on keeping documented Azzalure injection sites and doses consistent from one visit to the next.
Sourcing and Cold-Chain Considerations Between Sessions
Because botulinum toxin type A is temperature-sensitive, shipping conditions matter for this product class. Clinics that buy Azzalure wholesale should confirm cold-chain compliance and batch documentation with their distributor before accepting delivery, and ongoing shipping arrangements should include documented temperature logs across the full transit chain. Requirements to purchase Azzalure online vary by jurisdiction, and licensed professionals evaluating where to buy Azzalure wholesale from a new supplier should verify what their regional regulations permit before placing an order.
In What Ways Does Azzalure Behave Differently from Botox?
In discussions and comparisons like Azzalure vs Botox, practitioners must first know that they both use botulinum toxin type A, but they are not identical formulations. Azzalure behaves differently from Botox in ways that matter at the point of administration. The most consequential operational difference is that the two products use non-interchangeable dosing conventions. Azzalure is measured in Speywood units, and Speywood units cannot be substituted one-for-one for the units used in other botulinum toxin preparations [1].
That non-equivalence is central to any diffusion comparison between the two. In a randomized, double-blind study at equal labeled-unit doses, onabotulinumtoxinA (Botox) produced a larger field of anhidrotic effect than abobotulinumtoxinA [2]. The study does not establish that Azzalure inherently spreads farther than Botox. Rather, it shows that equal labeled-unit doses are not equivalent: in that experiment, onabotulinumtoxinA produced a larger field of anhidrotic effect than abobotulinumtoxinA. These findings reinforce that botulinum toxin products must be dosed according to their own unit systems and that their units are not interchangeable. Each product must be dosed according to its own unit system; its units should not be converted one-for-one to those of another preparation.
In practical terms, this means Azzalure should be planned and dosed using its product-specific Speywood-unit recommendations rather than by substituting or directly converting Botox units. Careful site selection matters regardless of formulation, particularly near the orbital rim, so that adjacent muscles like the levator palpebrae superioris are not inadvertently affected [1].
Which Conditions Is Azzalure Injection Approved to Treat?
Azzalure is licensed specifically for the temporary improvement in appearance of moderate to severe glabellar lines and lateral canthal lines in adult patients under 65, in cases where the lines have a meaningful psychological impact on the patient [1]. These are the conditions Azzalure itself is indicated for and treated with Azzalure in clinical practice.
Other botulinum toxin type A products (such as Botox) are licensed for therapeutic uses, including severe primary axillary hyperhidrosis (severe underarm sweating). In the United States, abobotulinumtoxinA marketed as Dysport has its own FDA-approved indications, including cervical dystonia, glabellar lines, and spasticity; axillary hyperhidrosis is not among those indications. Product indications vary by jurisdiction, so clinics should consult the applicable local product information.
More generally, some practitioners use botulinum toxin type A off-label for teeth grinding (bruxism). These are separate licensed indications and off-label applications of the broader molecule class. Azzalure’s own marketing authorization covers glabellar and lateral canthal lines only, and clinics should treat within a product’s licensed indications.
What Are the Documented Benefits of Azzalure Injection?
Referred to by some as the Azzalure wrinkle relaxing injection, it is documented to reduce the appearance of wrinkles that form from repeated facial muscle contraction. Frowning, squinting, and similar expressions create dynamic wrinkles that Azzalure is designed to soften, positioning the injectable as an active, safe, and effective option for practitioners managing expression-related lines.
In pivotal Phase III trials, patients typically saw a response within 2–3 days, with maximum effect at day 30. A significant reduction in glabellar line severity was maintained for up to four months, extending to five months in one study [1].
A real-world study that followed patients through multiple treatment cycles found that satisfaction remained high over time. The findings suggest Azzalure can effectively reduce expression-related fine lines and wrinkles, with results that hold up across repeated treatments [3]. Researchers have also studied its safety and effectiveness over multiple glabellar-line treatment cycles lasting up to 24 months [1].
What Side Effects Should Patients Expect?
Most side effects are mild, transient reactions at the injection site. Injection-site reactions — which may include redness, swelling, irritation, pain, discomfort, stinging, itching, or bruising — and headache are among the most frequently reported reactions after glabellar-line treatment [1]. For lateral canthal lines, eyelid edema and eyelid ptosis are also relatively common.
Less frequently, patients may experience dry eye, temporary facial muscle weakness near the injection site, or visual disturbances such as blurred vision [1]. Most treatment-related reactions occur within the first week and resolve on their own [1].
Azzalure is not recommended for patients who are pregnant or breastfeeding. It is also contraindicated in cases of hypersensitivity to the product, infection at the proposed injection site, or certain neuromuscular conditions such as myasthenia gravis [1].
Patients should seek medical attention promptly if they experience any unusual symptoms. These include swallowing, speech, or breathing difficulties after treatment, which can signal a rare but serious spread of the toxin’s effect [1].
Looking to buy Azzalure online? Get in touch with the Medica Depot support team for further guidance.
The contents of this page are meant for licensed medical professionals. They serve informational purposes only and are not to be taken as medical advice.
Citations
[1] Galderma (U.K.) Limited. “Azzalure, 125 Speywood Units, Powder for Solution for Injection: Summary of Product Characteristics (SmPC).” electronic Medicines Compendium (emc), 12 Feb. 2026, www.medicines.org.uk/emc/product/6584/smpc.
[2] Hexsel, Doris et al. “Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.” JAMA dermatology vol. 149,12 (2013): 1386-91. doi:10.1001/jamadermatol.2013.6440
[3] Gubanova, Elena et al. “Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport®/Azzalure®): Primary Results of the APPEAL Noninterventional Study.” Aesthetic plastic surgery vol. 42,6 (2018): 1672-1680. doi:10.1007/s00266-018-1200-4
This content was prepared and reviewed under our editorial guidelines , which govern how we source, verify, and update clinical and product information. Every claim is checked against peer-reviewed research, manufacturer documentation, or regulatory guidance before publication.
